Janus Henderson Group’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-430,000
Closed -$4.42M 2629
2023
Q2
$4.42M Hold
430,000
﹤0.01% 895
2023
Q1
$4.36M Buy
430,000
+380,000
+760% +$3.83M ﹤0.01% 918
2022
Q4
$500K Buy
+50,000
New +$492K ﹤0.01% 1722

Janus Henderson Group's DALS Position: Q3 2023 in Review

Janus Henderson Group sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 430,000 shares — an estimated $4.42M sold.

Janus Henderson Group first reported a position in DALS in Q4 2022 and held it in 3 quarters. The position peaked at $4.42M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Janus Henderson Group reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Janus Henderson Group sold 430,000 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $4.42M.
  • Janus Henderson Group first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 3 quarters.
  • Janus Henderson Group's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $4.42M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Janus Henderson Group's 13F filing for Q3 2023, filed 14 Nov 2023.